首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
Authors:Vinod Kumar  Paulisally Hau Yi Lo  Hiromi Sawai  Naoya Kato  Atsushi Takahashi  Zhenzhong Deng  Yuji Urabe  Hamdi Mbarek  Katsushi Tokunaga  Yasuhito Tanaka  Masaya Sugiyama  Masashi Mizokami  Ryosuke Muroyama  Ryosuke Tateishi  Masao Omata  Kazuhiko Koike  Chizu Tanikawa  Naoyuki Kamatani  Michiaki Kubo  Yusuke Nakamura  Koichi Matsuda
Abstract:MHC class I polypeptide-related chain A (MICA) molecule is induced in response to viral infection and various types of stress. We recently reported that a single nucleotide polymorphism (SNP) rs2596542 located in the MICA promoter region was significantly associated with the risk for hepatitis C virus (HCV)-induced hepatocellular carcinoma (HCC) and also with serum levels of soluble MICA (sMICA). In this study, we focused on the possible involvement of MICA in liver carcinogenesis related to hepatitis B virus (HBV) infection and examined correlation between the MICA polymorphism and the serum sMICA levels in HBV-induced HCC patients. The genetic association analysis revealed a nominal association with an SNP rs2596542; a G allele was considered to increase the risk of HBV-induced HCC (P = 0.029 with odds ratio of 1.19). We also found a significant elevation of sMICA in HBV-induced HCC cases. Moreover, a G allele of SNP rs2596542 was significantly associated with increased sMICA levels (P = 0.009). Interestingly, HCC patients with the high serum level of sMICA (>5 pg/ml) exhibited poorer prognosis than those with the low serum level of sMICA (≤5 pg/ml) (P = 0.008). Thus, our results highlight the importance of MICA genetic variations and the significance of sMICA as a predictive biomarker for HBV-induced HCC.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号